Editas Medicine, Inc. (LON:0IFK)
London · Delayed Price · Currency is GBP · Price in USD 2.610
+0.011 (0.42%)
At close: Aug 5, 2025
Splunk Market Cap
Editas Medicine has a market cap or net worth of 163.64 million as of August 6, 2025. Its market cap has decreased by -48.60% in one year.
Market Cap
163.64M
Enterprise Value
20.92M
Revenue
27.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.61
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from 425.65M to 163.64M, a decrease of -61.56%. That is a compound annual growth rate of -9.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 163.64M | 95.41% |
| Dec 31, 2024 | 83.74M | -87.11% |
| Dec 29, 2023 | 649.54M | 31.18% |
| Dec 30, 2022 | 495.14M | -62.67% |
| Dec 31, 2021 | 1.33B | -58.22% |
| Dec 31, 2020 | 3.17B | 180.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 3, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 172.68B |
| GSK plc | 56.24B |
| Haleon | 31.98B |
| Smith & Nephew | 10.10B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 4.25B |
| HUTCHMED (China) | 2.18B |
| Oxford Nanopore Technologies | 1.91B |